Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹25.25 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹25.25 Cr |
| Fresh Issue | ₹23.99 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹135.00 per share |
| Discount | Retail: 0.00,Employee: 13.50 |
| NSE Code | INFINIUM |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Swastika Investmart Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,000 shares and in multiples thereof
Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Marketing and Branding Expenses (including Registration in Reach - Europe, other marketing expenses) | 1.13 |
| 2 | Repayment of some of Existing Loans; | 3.92 |
| 3 | Expansion of Existing Unit | 5.05 |
| 4 | To Meet Incremental Working Capital Requirements; | 10.10 |
| 5 | General Corporate Purpose | 4.43 |
| Period Ended | 30 Sep 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 70.76 | 59.00 | 34.18 | 22.45 |
| Total Income | 79.85 | 100.05 | 71.15 | 39.42 |
| Profit After Tax | 5.51 | 6.11 | 2.72 | 0.93 |
| NET Worth | 18.56 | 13.10 | 7.02 | 4.25 |
| Reserves and Surplus | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Borrowing | 16.15 | 13.85 | 5.79 | 5.66 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2022 |
|---|---|
| ROE | 43.85% |
| ROCE | 72% |
| Debt / Equity | 2.91% |
| RoNW | 46.61% |
| PAT Margin | 6.16% |
| EBITDA Margin | 11.06% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 54.13 | |
| P/E (x) | 7.83 | |
| Promoter Holding | 100% | 73.05% |
| Market Cap | ₹93.93 Cr. | |
